Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025)

Koninklijke Philips' (PHG) quarterly Cash from Discontinued Operations came in at 11640435.15 in Q4 2025, up 16.21% year-on-year from 10017062.97 in Q4 2024, and little changed quarter-over-quarter from 11690550.91 in Q3 2025.

Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends

Koninklijke Philips' Cash from Discontinued Operations history runs 17 years deep, the most recent figure standing at 11640435.15 for Q4 2025.

  • On a quarterly basis, Cash from Discontinued Operations rose 16.21% year-over-year to 11640435.15 in Q4 2025; TTM through Dec 2025 was 45169427.34, a 34.85% increase from a year earlier, with the FY2023 full-year figure at 132340608.8, up 580.42% from the prior year.
  • Cash from Discontinued Operations steadied at 11640435.15 in Q4 2025 per PHG's latest filing, from 11690550.91 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 4552049064.24 in Q3 2021 and bottomed at 61889287.92 in Q2 2022.
  • The 5-year median for Cash from Discontinued Operations is 10919220.64 (2025), against an average of 424390806.45.
  • Across the five-year window, Cash from Discontinued Operations soared 2431.08% in 2021 and plunged 330.16% in 2024, its largest moves.
  • Year by year, Cash from Discontinued Operations stood at 3892933146.71 in 2021, then plunged by 100.31% to 12242968.38 in 2022, then jumped by 275.76% to 21518798.18 in 2023, then tumbled by 164.56% to 13891740.2 in 2024, then increased by 16.21% to 11640435.15 in 2025.
  • Per Business Quant, the three latest PHG Cash from Discontinued Operations figures stand at 11640435.15 (Q4 2025), 11690550.91 (Q3 2025), and 11319596.88 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -11.64 Mn
Dec 31, 2025 -11.64 Mn
Sep 30, 2025 -11.69 Mn
Sep 30, 2025 -11.69 Mn
Jun 30, 2025 -11.32 Mn
Jun 30, 2025 -11.32 Mn
Mar 31, 2025 -10.52 Mn
Mar 31, 2025 -10.52 Mn
Dec 31, 2024 -13.89 Mn
Dec 31, 2024 -13.89 Mn
Sep 30, 2024 -18.67 Mn
Sep 30, 2024 -18.67 Mn
Jun 30, 2024 -18.31 Mn
Jun 30, 2024 -18.31 Mn
Mar 31, 2024 -18.47 Mn
Mar 31, 2024 -18.47 Mn
Dec 31, 2023 21.52 Mn
Dec 31, 2023 21.52 Mn
Sep 30, 2023 87.09 Mn
Sep 30, 2023 87.09 Mn